Merel Gijsen

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

Alexandra Canonici, Merel Gijsen, Maeve Mullooly et al. · Oncotarget · 2013 · 162 citations · Full text

Trastuzumab Resistance, Breast Oncology, Trastuzumab-sensitive Breast Cancer +13

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer

Merel Gijsen, Peter King, Tim Perera et al. · PLoS Biology · 2010 · 128 citations · Full text

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer

Katharina Feldinger, Daniele Generali, Gabriela Krämer-Marek et al. · Oncotarget · 2014 · 88 citations · Full text

Ubiquitination by the Membrane-associated RING-CH-8 (MARCH-8) Ligase Controls Steady-state Cell Surface Expression of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Receptor 1*

Bert van de Kooij, Inge Verbrugge, Evert de Vries et al. · Journal of Biological Chemistry · 2013 · 85 citations · Full text

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer

Siti Norasikin Mohd Nafi, Daniele Generali, Gabriela Krämer-Marek et al. · Oncotarget · 2014 · 63 citations · Full text